首页> 外文会议>Society for Biomaterials annual meeting and exposition >Preventing Hypoxia-induced Beta Cell Death and Dysfunction via Oxygen-generating Microbeads
【24h】

Preventing Hypoxia-induced Beta Cell Death and Dysfunction via Oxygen-generating Microbeads

机译:通过产生氧气的微珠预防缺氧诱导的β细胞死亡和功能障碍

获取原文

摘要

The OxySite biomaterial can be reproducibly fabricated into a microbead form within the desired size range. These microbeads can generate oxygen for more than 30 days, with minimal cytotoxic byproducts or environmental changes. Compared to control PDMS-only microbeads, the co-culture of beta cells with OxySite microbeads within immunoisolatory agarose macrogels resulted in sustained and significant elevations in viability and functionality under hypoxic condition in vitro. With these promising results, and the flexibility of the OxySite microbead platform, this approach could be easily translated to numerous tissue engineered platforms. Future work will explore the potential of this platform to improve efficacy of transplants in diabetic mice.
机译:OxySite生物材料可以可复制地制成所需大小范围内的微珠形式。这些微珠可产生氧气超过30天,而细胞毒性副产物或环境变化最小。与仅使用PDMS的对照微珠相比,β细胞与OxySite微珠在免疫隔离琼脂糖大凝胶中的共培养导致体外低氧条件下活力和功能的持续显着提高。有了这些令人鼓舞的结果,以及OxySite微珠平台的灵活性,这种方法可以轻松地转化为众多组织工程平台。未来的工作将探索该平台改善糖尿病小鼠移植功效的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号